MKI67 and cancer: Thirdly, clinical markers that may affect bone metastasis of cancer, including BRAF mutation, calcitonin, TERT mutation, and Ki-67 index, were not included in this study (9, 47, 48), and we will continue to expand our data collection to further improve our model in the future.